When a manufacturer fails to provide adequate warnings about known product dangers, consumers suffer preventable injuries. Failure to warn defects—also called marketing defects—represent one of four types of product liability claims recognized under Louisiana law. Even products that are properly designed and manufactured can be unreasonably dangerous if they lack clear, conspicuous warnings about risks consumers need to know before use.
At Smiley Injury Law, our New Orleans product liability lawyers represent Louisiana consumers injured because manufacturers hid dangers, provided unclear warnings, or failed to include necessary safety instructions. Understanding failure to warn claims helps you recognize when inadequate warnings—not defective design or manufacturing—caused your injuries.
What Is a Failure to Warn Defect?
A failure to warn defect, also called a marketing defect, occurs when a manufacturer does not provide adequate warnings or instructions about known product dangers, making an otherwise properly designed and manufactured product unreasonably dangerous. Even if a product works exactly as intended, manufacturers can face liability if they fail to alert consumers to risks associated with the product’s use through clear, conspicuous, and specific warnings that enable informed decisions and safe use. The duty to warn extends to dangers the manufacturer knew about or should have discovered through reasonable testing.
Under the Louisiana Products Liability Act (LPLA), a product is unreasonably dangerous because an adequate warning has not been provided when the product possesses a characteristic that may cause damage and the manufacturer failed to use reasonable care to provide an adequate warning about that characteristic and its danger.
The key distinction with failure to warn claims is that the product itself may function properly—the danger lies in what consumers weren’t told. If appropriate warnings would have allowed you to avoid injury, the manufacturer’s failure to provide those warnings creates liability.
What Makes a Warning “Adequate” Under Louisiana Law?
Louisiana courts evaluate warning adequacy by examining whether the warning effectively communicates the nature and extent of product dangers to consumers. Generic cautionary language isn’t enough—warnings must specifically address known risks in ways that enable informed decisions.
Requirements for Adequate Warnings
Adequate warnings under Louisiana law must be:
Clear and Understandable
Warnings must use language the intended audience can comprehend. Technical jargon may be appropriate for products sold to trained professionals but inadequate for consumer products used by the general public. Warnings must be written at an appropriate reading level and may need to be provided in multiple languages depending on the expected user population.
Conspicuous and Prominent
Warnings must be placed where users will actually see them before encountering the danger. A warning buried in fine print on the last page of a manual may be inadequate if the danger exists upon first use. Warning placement, size, color, and formatting all affect whether warnings adequately alert consumers to dangers.
Specific About the Danger
Adequate warnings identify the specific nature of the hazard and the consequences of ignoring the warning. “Use with caution” fails to inform consumers what they should be cautious about. “May cause severe chemical burns if product contacts skin” specifically describes the danger and its consequences.
Complete About All Known Risks
Manufacturers must warn about all known dangers, not just the most common or most severe. A medication warning that discloses headache as a side effect but omits known risks of liver damage fails to adequately inform consumers about significant dangers.
Updated When New Dangers Emerge
The duty to warn continues after products reach the market. When manufacturers learn of previously unknown dangers, they must update warnings and take reasonable steps to inform existing users. Failure to update warnings as new risks emerge creates liability for injuries the updated warnings would have prevented.
Common Examples of Failure to Warn Defects
Failure to warn claims arise across all product categories when manufacturers fail to adequately communicate known dangers.
Pharmaceutical Failure to Warn
Drug manufacturers face extensive warning obligations:
- Undisclosed side effects – Medications lacking warnings about known adverse reactions
- Drug interaction risks – Failure to warn about dangerous interactions with other medications
- Contraindication warnings – Missing information about conditions that make the drug dangerous
- Dosing dangers – Inadequate instructions about maximum dosages or frequency
- Withdrawal risks – Failure to warn about dangers of discontinuing medication